Literature DB >> 11400358

Ras, metastasis, and matrix metalloproteinase 9.

E J Bernhard1, R J Muschel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400358     DOI: 10.1016/s0076-6879(01)33048-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.

Authors:  Rashmi Choudhary; Howard Li; Robert A Winn; Amber L Sorenson; Mary C M Weiser-Evans; Raphael A Nemenoff
Journal:  Neoplasia       Date:  2010-03       Impact factor: 5.715

2.  Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.

Authors:  Juran Kato-Stankiewicz; Irina Hakimi; Gang Zhi; Jie Zhang; Ilya Serebriiskii; Lea Guo; Hironori Edamatsu; Hiroshi Koide; Sanjay Menon; Robert Eckl; Sukumar Sakamuri; Yingchun Lu; Quin-Zene Chen; Seema Agarwal; William R Baumbach; Erica A Golemis; Fuyuhiko Tamanoi; Vladimir Khazak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

3.  Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.

Authors:  Thomas R Johnson; Sweaty Koul; Binod Kumar; Lakshmipathi Khandrika; Sarah Venezia; Paul D Maroni; Randall B Meacham; Hari K Koul
Journal:  Mol Cancer       Date:  2010-06-15       Impact factor: 27.401

4.  p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.

Authors:  B Marengo; C G De Ciucis; R Ricciarelli; A L Furfaro; R Colla; E Canepa; N Traverso; U M Marinari; M A Pronzato; C Domenicotti
Journal:  Cell Death Dis       Date:  2013-04-11       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.